Patents by Inventor Nipavan Chiamvimonvat

Nipavan Chiamvimonvat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of improving cell-based therapy
    Patent number: 11723929
    Abstract: Provided are methods for improving the efficacy and success of cell-based therapies by administration of stem cells which have been preconditioned with an inhibitor of soluble epoxide hydrolase (sEHI), as well as kits, stents and patches for administering sEHI-preconditioned stem cells, as sole active agent or in combination with an agent that increases the production and or levels of EETs.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: August 15, 2023
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Nipavan Chiamvimonvat, Bruce D. Hammock, Padmini Sirish
  • Methods of improving cell-based therapy
    Patent number: 11690837
    Abstract: Provided are methods for improving cell-based therapies by co-administration with an agent that increases the production and or levels of epoxygenated fatty acids, as well as kits, stents and patches for co-administering stem cells with an agent that increases the production and/or levels of epoxygenated fatty acids.
    Type: Grant
    Filed: June 19, 2019
    Date of Patent: July 4, 2023
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Nipavan Chiamvimonvat, Bruce D. Hammock
  • GLYCOCALYX MIMETIC COATINGS
    Publication number: 20220133897
    Abstract: Provided herein are selectin-binding peptide ligands having both D- and L-amino acids, and peptide conjugates including the provided peptide ligands. The peptide conjugates can include a biopolymer backbone, such as dermatan sulfate, and 33 or fewer peptide ligands conjugated to the biopolymer. Also provided are methods for using the provided peptide conjugates to treat patients suffering from endothelial dysfunction.
    Type: Application
    Filed: September 9, 2021
    Publication date: May 5, 2022
    Applicant: The Regents of The University of California
    Inventors: Alyssa Panitch, Tima Dehghani, Harkanwalpreet Sodhi, Kit Lam, Ruiwu Liu, Xiaocen Li, Nipavan Chiamvimonvat, Phung N. Thai
  • METHODS OF IMPROVING CELL-BASED THERAPY
    Publication number: 20210145891
    Abstract: Provided are methods for improving the efficacy and success of cell-based therapies by administration of stem cells which have been preconditioned with an inhibitor of soluble epoxide hydrolase (sEHI), as well as kits, stents and patches for administering sEHI-preconditioned stem cells, as sole active agent or in combination with an agent that increases the production and or levels of EETs.
    Type: Application
    Filed: June 11, 2018
    Publication date: May 20, 2021
    Inventors: Nipavan CHIAMVIMONVAT, Bruce D. HAMMOCK, Padmini SIRISH
  • METHODS OF IMPROVING CELL-BASED THERAPY
    Publication number: 20190365733
    Abstract: Provided are methods for improving cell-based therapies by co-administration with an agent that increases the production and or levels of epoxygenated fatty acids, as well as kits, stents and patches for co-administering stem cells with an agent that increases the production and/or levels of epoxygenated fatty acids.
    Type: Application
    Filed: June 19, 2019
    Publication date: December 5, 2019
    Inventors: Nipavan CHIAMVIMONVAT, Bruce D. HAMMOCK
  • Methods of improving cell-based therapy
    Patent number: 10369141
    Abstract: Provided are methods for improving cell-based therapies by co-administration with an agent that increases the production and or levels of epoxygenated fatty acids, as well as kits, stents and patches for co-administering stem cells with an agent that increases the production and/or levels of epoxygenated fatty acids.
    Type: Grant
    Filed: March 8, 2018
    Date of Patent: August 6, 2019
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Nipavan Chiamvimonvat, Bruce D. Hammock
  • METHODS OF IMPROVING CELL-BASED THERAPY
    Publication number: 20180200244
    Abstract: Provided are methods for improving cell-based therapies by co-administration with an agent that increases the production and or levels of epoxygenated fatty acids, as well as kits, stents and patches for co-administering stem cells with an agent that increases the production and/or levels of epoxygenated fatty acids.
    Type: Application
    Filed: March 8, 2018
    Publication date: July 19, 2018
    Applicant: The Regents of the University of California
    Inventors: Nipavan CHIAMVIMONVAT, Bruce D. HAMMOCK
  • METHODS OF IMPROVING CELL-BASED THERAPY
    Publication number: 20160008342
    Abstract: Provided are methods for improving cell-based therapies by co-administration with an agent that increases the production and or levels of epoxygenated fatty acids, as well as kits, stents and patches for co-administering stem cells with an agent that increases the production and/or levels of epoxygenated fatty acids.
    Type: Application
    Filed: June 11, 2015
    Publication date: January 14, 2016
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Nipavan CHIAMVIMONVAT, Bruce D. HAMMOCK
  • Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy
    Patent number: 8242170
    Abstract: The invention provides methods for inhibiting cardiomyopathy and for inhibiting cardiac arrhythmia, by administering to an individual in need thereof a cis-epoxyeicosantrienoic acid, an inhibitor of soluble epoxide hydrolase (sEH), or both. In some embodiments, the method comprises administering to the individual a nucleic acid encoding an inhibitor of sEH. Cardiomyopathies treatable by the methods of the invention include cardiac hypertrophy and dilated cardiomyopathy.
    Type: Grant
    Filed: June 6, 2006
    Date of Patent: August 14, 2012
    Assignee: The Regents of the University of California
    Inventors: Nipavan Chiamvimonvat, Bruce D. Hammock
  • Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy
    Publication number: 20090216318
    Abstract: The invention provides methods for inhibiting cardiomyopathy and for inhibiting cardiac arrhythmia, by administering to an individual in need thereof a cis-epoxyeicosantrienoic acid, an inhibitor of soluble epoxide hydrolase (sEH), or both. In some embodiments, the method comprises administering to the individual a nucleic acid encoding an inhibitor of sEH. Cardiomyopathies treatable by the methods of the invention include cardiac hypertrophy and dilated cardiomyopathy.
    Type: Application
    Filed: June 6, 2006
    Publication date: August 27, 2009
    Inventors: Nipavan Chiamvimonvat, Bruce D. Hammock